TGIF2LY
geneOn this page
Summary
TGIF2LY (TGFB induced factor homeobox 2 like Y-linked, HGNC:18569) is a protein-coding gene on chromosome Yp11.2, encoding Homeobox protein TGIF2LY (Q8IUE0). May have a transcription role in testis.
This gene encodes a member of the TALE/TGIF homeobox family of transcription factors. This gene lies within the male specific region of chromosome Y, in a block of sequence that is thought to be the result of a large X-to-Y transposition. The C-terminus of this protein is divergent from that of its chromosome X homolog (TGIF2LX), suggesting that this protein may act as a regulator of TGIF2LX.
Source: NCBI Gene 90655 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 9 total — 1 pathogenic, 1 likely-pathogenic
- MANE Select transcript:
NM_139214
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18569 |
| Approved symbol | TGIF2LY |
| Name | TGFB induced factor homeobox 2 like Y-linked |
| Location | Yp11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000176679 |
| Ensembl biotype | protein_coding |
| OMIM | 400025 |
| Entrez | 90655 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000321217, ENST00000559055
RefSeq mRNA: 1 — MANE Select: NM_139214
NM_139214
CCDS: CCDS14775
Canonical transcript exons
ENST00000321217 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001091887 | 3579067 | 3579127 |
| ENSE00001889836 | 3579224 | 3580041 |
Expression profiles
Bgee: expression breadth tissue_specific, 7 present calls, max score 86.77.
Top tissues by expression
131 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.77 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.58 | gold quality |
| testis | UBERON:0000473 | 62.44 | gold quality |
| left testis | UBERON:0004533 | 61.65 | gold quality |
| right testis | UBERON:0004534 | 59.29 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| liver | UBERON:0002107 | 29.36 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| right coronary artery | UBERON:0001625 | 27.84 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| leukocyte | CL:0000738 | 27.54 | gold quality |
| monocyte | CL:0000576 | 27.53 | gold quality |
| primary visual cortex | UBERON:0002436 | 27.27 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.16 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA1572.1 | TGIF2LY | TALE-type homeo domain factors |
JASPAR matrix evidence (PMIDs): PMID:8537382
miRNA regulators (miRDB)
18 targeting TGIF2LY, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4516 | 99.61 | 67.78 | 3390 |
| HSA-MIR-516B-5P | 99.56 | 66.33 | 1495 |
| HSA-MIR-6839-3P | 99.39 | 68.86 | 1301 |
| HSA-MIR-5703 | 99.10 | 67.09 | 2053 |
| HSA-MIR-4434 | 99.10 | 67.01 | 1984 |
| HSA-MIR-4651 | 99.06 | 67.57 | 2002 |
| HSA-MIR-140-3P | 99.04 | 67.69 | 1324 |
| HSA-MIR-4801 | 98.96 | 69.42 | 2096 |
| HSA-MIR-608 | 98.93 | 67.83 | 2013 |
| HSA-MIR-4731-3P | 98.56 | 68.60 | 1860 |
| HSA-MIR-2681-3P | 98.18 | 65.28 | 577 |
| HSA-MIR-4664-5P | 98.17 | 65.07 | 1020 |
| HSA-MIR-93-3P | 98.15 | 66.65 | 1309 |
| HSA-MIR-12126 | 98.09 | 64.82 | 637 |
| HSA-MIR-342-5P | 97.25 | 64.10 | 817 |
| HSA-MIR-6759-3P | 96.94 | 68.31 | 823 |
| HSA-MIR-490-5P | 96.75 | 65.81 | 661 |
| HSA-MIR-6747-5P | 96.17 | 64.99 | 743 |
Literature-anchored findings (GeneRIF, showing 2)
- Association of TGIFLX/Y mRNA expression with azoospermia in infertile men.( (PMID:18384077)
- most prostate tumors (73.5%) express at least one of these genes (TGIFLX and TGIFLY), although different patterns of mRNA expression were observed. These results suggest an association of TGIFLX/Y expression with the progression of prostate cancer. (PMID:18663611)
Cross-species orthologs
12 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | pbx2 | ENSDARG00000019717 |
| danio_rerio | pbx4 | ENSDARG00000052150 |
| mus_musculus | Tgif2lx1 | ENSMUSG00000100133 |
| mus_musculus | Tgif2lx2 | ENSMUSG00000100194 |
| rattus_norvegicus | Tgif2lx2 | ENSRNOG00000029850 |
| drosophila_melanogaster | exd | FBGN0000611 |
| drosophila_melanogaster | hth | FBGN0001235 |
| drosophila_melanogaster | vis | FBGN0033748 |
| drosophila_melanogaster | achi | FBGN0033749 |
| caenorhabditis_elegans | WBGENE00000443 | |
| caenorhabditis_elegans | WBGENE00006796 | |
| caenorhabditis_elegans | WBGENE00017690 |
Paralogs (13): MEIS3 (ENSG00000105419), PBX4 (ENSG00000105717), TGIF2 (ENSG00000118707), MEIS2 (ENSG00000134138), MEIS1 (ENSG00000143995), TGIF2LX (ENSG00000153779), PKNOX1 (ENSG00000160199), PKNOX2 (ENSG00000165495), PBX3 (ENSG00000167081), TGIF1 (ENSG00000177426), PBX1 (ENSG00000185630), MEIS3P2 (ENSG00000188013), PBX2 (ENSG00000204304)
Protein
Protein identifiers
Homeobox protein TGIF2LY — Q8IUE0 (reviewed: Q8IUE0)
Alternative names: TGF-beta-induced transcription factor 2-like protein, TGFB-induced factor 2-like protein, Y-linked, TGIF-like on the Y
All UniProt accessions (1): Q8IUE0
UniProt curated annotations — full annotation on UniProt →
Function. May have a transcription role in testis. May act as a competitor/regulator of TGIF2LX.
Subcellular location. Nucleus.
Tissue specificity. Specifically expressed in adult testis.
Similarity. Belongs to the TALE/TGIF homeobox family.
RefSeq proteins (1): NP_631960* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001356 | HD | Domain |
| IPR008422 | KN_HD | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR050224 | TALE_homeobox | Family |
Pfam: PF05920
UniProt features (5 total): region of interest 2, chain 1, DNA-binding region 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IUE0-F1 | 69.27 | 0.29 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 22 (showing top):
ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, chrYp11, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOMF_DNA_BINDING_TRANSCRIPTION_REPRESSOR_ACTIVITY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_DN, GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_DN, GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_DN, FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, PULVER_FOREY_PERTURB_ACCUMULATION_G2_M, GOMF_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING
GO Biological Process (2): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), protein binding (GO:0005515)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of transcription by RNA polymerase II | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| negative regulation of transcription by RNA polymerase II | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription repressor activity | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
586 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TGIF2LY | PABPC5 | Q96DU9 | 930 |
| TGIF2LY | PCDH11X | Q9BZA7 | 887 |
| TGIF2LY | TGFBI | Q15582 | 846 |
| TGIF2LY | A0A087WUC5 | A0A087WUC5 | 703 |
| TGIF2LY | VCY | O14598 | 621 |
| TGIF2LY | A6NEC3 | A6NEC3 | 581 |
| TGIF2LY | TSPY1 | P09002 | 571 |
| TGIF2LY | AMELY | Q99218 | 555 |
| TGIF2LY | CDY2A | Q9Y6F7 | 546 |
| TGIF2LY | TSPY4 | P0CV99 | 545 |
| TGIF2LY | PRKY | O43930 | 519 |
| TGIF2LY | CDY1 | Q9Y6F8 | 516 |
| TGIF2LY | BPY2 | O14599 | 506 |
| TGIF2LY | HSFY1 | Q96LI6 | 493 |
| TGIF2LY | RBMY1B | A6NDE4 | 491 |
IntAct
18 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TGIF2LY | NAB2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| NAB2 | TGIF2LY | psi-mi:“MI:0915”(physical association) | 0.720 |
| TGIF2LY | PGP | psi-mi:“MI:0914”(association) | 0.640 |
| TGIF2LY | MBIP | psi-mi:“MI:0915”(physical association) | 0.560 |
| MBIP | TGIF2LY | psi-mi:“MI:0915”(physical association) | 0.560 |
| YWHAZ | LMNA | psi-mi:“MI:0914”(association) | 0.560 |
| HAUS1 | BET1 | psi-mi:“MI:0914”(association) | 0.530 |
| PCBD2 | TGIF2LY | psi-mi:“MI:0915”(physical association) | 0.370 |
| NOTCH2NLA | IGKC | psi-mi:“MI:0914”(association) | 0.350 |
| TGIF2LX | TNRC18 | psi-mi:“MI:0914”(association) | 0.350 |
| TGIF2LY | NAB2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (54): TGIF2LY (Two-hybrid), TGIF2LY (Two-hybrid), TGIF2LX (Affinity Capture-MS), LRP6 (Affinity Capture-MS), PDCD4 (Affinity Capture-MS), ANKHD1-EIF4EBP3 (Affinity Capture-MS), OGFR (Affinity Capture-MS), CRBN (Affinity Capture-MS), AHCYL2 (Affinity Capture-MS), PGP (Affinity Capture-MS), GMNN (Affinity Capture-MS), DCAF16 (Affinity Capture-MS), THNSL1 (Affinity Capture-MS), LRP5 (Affinity Capture-MS), IRGQ (Affinity Capture-MS)
ESM2 similar proteins: A0A1B0GTS1, A0A1B0GWH4, A1A4L6, A1YGI6, A6NDR6, B8QB46, F1MJR8, F1QDF8, O35892, O35893, P09015, P15036, P15037, P23497, P52729, P59598, Q32NH9, Q3KRF1, Q3UM89, Q4G112, Q4V7E1, Q5M7N6, Q5ND04, Q5XIV2, Q5ZHX5, Q66IG8, Q6P1R3, Q6PCX9, Q6PJQ5, Q708W2, Q76I76, Q76I79, Q76N89, Q7M6U3, Q8AXQ4, Q8BVK9, Q8IUE0, Q8IUE1, Q8IWB6, Q8IXJ9
Diamond homologs: A1YGI6, A6NDR6, A8K0S8, A8WL06, B7ZRT8, O00470, O04136, O14770, O22300, O42261, O46339, O65685, O70477, P41779, P41817, P46606, P48000, P48001, P48002, P48731, P53147, P54269, P55347, P56659, P56660, P56664, P56665, P56669, P70284, P78412, P78413, P78414, P78415, P79937, P81067, P81068, P97367, P97368, Q0E3C3, Q0J6N4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
9 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 1 |
| Uncertain significance | 5 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1703656 | GRCh37/hg19 Yp11.31-11.2(chrY:2650140-7114097) | Pathogenic |
| 2690971 | NM_139214.3(TGIF2LY):c.534_535del (p.Leu179fs) | Likely pathogenic |
SpliceAI
108 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| Y:3579222:A:AG | acceptor_gain | 0.9700 |
| Y:3579223:G:GG | acceptor_gain | 0.9700 |
| Y:3579223:GTAAC:G | acceptor_gain | 0.9600 |
| Y:3579223:GT:G | acceptor_gain | 0.9500 |
| Y:3579246:T:TA | acceptor_gain | 0.9500 |
| Y:3579245:AT:A | acceptor_gain | 0.9400 |
| Y:3579125:CAGGT:C | donor_loss | 0.9200 |
| Y:3579128:G:GA | donor_loss | 0.9200 |
| Y:3579129:T:G | donor_loss | 0.9200 |
| Y:3579223:GTA:G | acceptor_gain | 0.9100 |
| Y:3579246:T:G | acceptor_gain | 0.8900 |
| Y:3579223:GTAA:G | acceptor_gain | 0.8800 |
| Y:3579248:G:C | acceptor_gain | 0.8600 |
| Y:3579246:TGG:T | acceptor_gain | 0.8500 |
| Y:3579244:TATGG:T | acceptor_gain | 0.8400 |
| Y:3579245:ATGGA:A | acceptor_gain | 0.8400 |
| Y:3579130:GAGAA:G | donor_loss | 0.8300 |
| Y:3579247:G:A | acceptor_gain | 0.8200 |
| Y:3579217:A:AG | acceptor_gain | 0.8100 |
| Y:3579221:T:G | acceptor_gain | 0.7700 |
| Y:3579221:TA:T | acceptor_loss | 0.7500 |
| Y:3579222:A:AC | acceptor_loss | 0.7500 |
| Y:3579209:T:TA | acceptor_loss | 0.7400 |
| Y:3579218:A:G | acceptor_gain | 0.7300 |
| Y:3579207:T:TA | acceptor_loss | 0.7200 |
| Y:3579246:TGGAG:T | acceptor_gain | 0.7100 |
| Y:3579247:GGAGG:G | acceptor_gain | 0.7100 |
| Y:3579220:A:AG | acceptor_gain | 0.6900 |
| Y:3579211:A:AG | acceptor_loss | 0.6700 |
| Y:3579248:G:T | acceptor_loss | 0.6400 |
AlphaMissense
1212 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| Y:3579545:T:C | F101L | 0.986 |
| Y:3579547:T:A | F101L | 0.986 |
| Y:3579547:T:G | F101L | 0.986 |
| Y:3579546:T:C | F101S | 0.957 |
| Y:3579448:G:C | W68C | 0.954 |
| Y:3579448:G:T | W68C | 0.954 |
| Y:3579542:T:A | W100R | 0.954 |
| Y:3579542:T:C | W100R | 0.954 |
| Y:3579544:G:C | W100C | 0.954 |
| Y:3579544:G:T | W100C | 0.954 |
| Y:3579464:T:C | F74L | 0.939 |
| Y:3579466:T:A | F74L | 0.939 |
| Y:3579466:T:G | F74L | 0.939 |
| Y:3579493:G:C | K83N | 0.939 |
| Y:3579493:G:T | K83N | 0.939 |
| Y:3579438:T:A | L65H | 0.935 |
| Y:3579446:T:A | W68R | 0.935 |
| Y:3579446:T:C | W68R | 0.935 |
| Y:3579476:C:T | P78S | 0.931 |
| Y:3579513:C:T | T90I | 0.926 |
| Y:3579564:G:C | R107P | 0.924 |
| Y:3579441:G:C | R66P | 0.922 |
| Y:3579546:T:G | F101C | 0.922 |
| Y:3579450:T:C | M69T | 0.920 |
| Y:3579557:C:A | R105S | 0.919 |
| Y:3579562:A:C | R106S | 0.904 |
| Y:3579562:A:T | R106S | 0.904 |
| Y:3579438:T:C | L65P | 0.900 |
| Y:3579519:T:C | L92S | 0.899 |
| Y:3579553:T:A | N103K | 0.897 |
dbSNP variants (sampled 300 via entrez): RS1053786 (Y:3579810 A>G), RS1053787 (Y:3579826 A>G), RS1053788 (Y:3579837 T>A), RS1053790 (Y:3579874 T>C), RS1053791 (Y:3579923 C>G), RS112167115 (Y:3577672 A>T), RS112346061 (Y:3578280 C>T), RS1159760707 (Y:3579667 T>C), RS1177697814 (Y:3578549 A>T), RS1188148342 (Y:3579262 C>G), RS1198521244 (Y:3579658 C>A,T), RS1201007545 (Y:3579425 T>C), RS1209453421 (Y:3579779 C>T), RS1230924360 (Y:3577073 A>G), RS1233642961 (Y:3579552 A>G)
Disease associations
OMIM: gene MIM:400025 | disease phenotypes: MIM:400045
GenCC curated gene-disease
Mondo (1): 46,XX sex reversal 1 (MONDO:0100250)
Orphanet (1): Male infertility with azoospermia or oligozoospermia due to single gene mutation (Orphanet:399805)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | increases reaction, affects binding | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cadmium | increases expression, increases abundance | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): 46,XX sex reversal 1